| 0 (0%) | 06-09 17:21 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.33  |
1-year : | 3.94 |
| Resists | First : | 2.85 |
Second : | 3.38 |
| Pivot price | 2.56 |
|||
| Supports | First : | 2 |
Second : | 1.67 |
| MAs | MA(5) : | 2.5 |
MA(20) : | 2.61 |
| MA(100) : | 2.68 |
MA(250) : | 4.68 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 10.9 |
D(3) : | 22.6 |
| RSI | RSI(14): 35.3 |
|||
| 52-week | High : | 19.62 | Low : | 1.75 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ PCSA ] has closed below the lower bollinger band by 18.0%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ PCSA ] is to continue within current trading range. Bollinger Bands are 17.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.6 - 2.62 | 2.62 - 2.64 |
| Low: | 1.97 - 1.99 | 1.99 - 2.01 |
| Close: | 2.01 - 2.05 | 2.05 - 2.07 |
Mon, 08 Jun 2026
Processa Pharmaceuticals, Inc. - MLQ.ai
Fri, 05 Jun 2026
PCSA Stock Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill
Wed, 03 Jun 2026
In Senate hearing, Pac-12 commissioner Gould calls for NCAA to consider collective bargaining - The Mercury News
Mon, 01 Jun 2026
Insider Buying: Russell Skibsted Acquires Additional Shares of P - GuruFocus
Mon, 01 Jun 2026
Processa Pharmaceuticals (PCSA) R&D chief buys 1,786 shares at $2.57 - Stock Titan
Mon, 01 Jun 2026
Processa Pharmaceuticals (PCSA) CFO adds 2,292 shares in open-market buy - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 3 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 13.7 (%) |
| Held by Institutions | 10.3 (%) |
| Shares Short | 117 (K) |
| Shares Short P.Month | 104 (K) |
| EPS | -4.08 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.94 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -193.9 % |
| Return on Equity (ttm) | -465 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -5.27 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.5 |
| PEG Ratio | 0 |
| Price to Book value | 2.14 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.46 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|